Information is solely for medical professionals
Beifuji Spray
Bovine Basic Fibroblast Growth Factor Spray
/
Specification 63000IU/15ml/bottle
Beifuji is a national category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..
The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
Mechanism
The API of Beifuji is recombinant bovine basic fibroblast growth factor (rb-bFGF), which can stimulate the repair and regeneration of tissues and cells derived from the mesoderm and ectoderm (such as epithelial cells, dermal cells, fibroblasts, vascular endothelial cells, osteoblasts, nerve cells etc.). The specific combination of rb-bFGF with the wounded target cell surface can trigger the cells to repair actively and stimulate cell division, proliferation, migration and differentiation, so as to accelerate wound healing and improve the healing quality.
Features
· A state category I new drug based on the genetic engineering technology
· Accelerate wound healing shortening the healing time and reducing scar formation
· Safe and effective treatment without any side effect
· Sterile formulation packaged aseptically, convenient for use
· Accelerate wound healing shortening the healing time and reducing scar formation
· Safe and effective treatment without any side effect
· Sterile formulation packaged aseptically, convenient for use
Clinical Application
· Burn and scald wounds: including shallow II degree and deep II degree wounds,granulation wounds and inhalation injuries
· Acute wounds: bruises, contusions, combined injuries and cuts
· Surgical incisions: incisions of surgery, orthopedics, gynaecology (such as lateral episiotomy and cesarean incision), otolaryngology, urology and proctology
· Chronic wounds: diabetic ulcers, vascular ulcers, radiochemotherapy ulcers, bedsores, fistulas, residual wounds and cervical erosions
· Skin grafting: skin donor site, skin grafting site, skin flap handling
· Other applications: after plastic surgery, skin resurfacing, dermabrasion, nevus removal and laser therapy wounds
· Acute wounds: bruises, contusions, combined injuries and cuts
· Surgical incisions: incisions of surgery, orthopedics, gynaecology (such as lateral episiotomy and cesarean incision), otolaryngology, urology and proctology
· Chronic wounds: diabetic ulcers, vascular ulcers, radiochemotherapy ulcers, bedsores, fistulas, residual wounds and cervical erosions
· Skin grafting: skin donor site, skin grafting site, skin flap handling
· Other applications: after plastic surgery, skin resurfacing, dermabrasion, nevus removal and laser therapy wounds
Medical Guidelines
· Chinese Dermatologist Consensus about Application of Recombinant Bovine Basic Fibroblast Growth Factor (rb-bFGF) for Laser and IPLS Treatment and Skin Barrier Repairment(2019)
· Clinical Guidelines for Use of Exogenous Growth Factors in Skin Wounds, Chin J Burns(2017)
· Expert Advice on Diagnosis and Treatment of Pemphigus Vulgaris (2016)
· Chinese Guidelines for Diagnosis and Treatment of Skin Wounds (2015)
· Clinical Guidelines for Use of Exogenous Growth Factors in Skin Wounds, Chin J Burns(2017)
· Expert Advice on Diagnosis and Treatment of Pemphigus Vulgaris (2016)
· Chinese Guidelines for Diagnosis and Treatment of Skin Wounds (2015)
粵公網安備 44049102496184號